This inventor holds 2 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Denka Seiken Co., Ltd., Niigata University, Juntendo Education Foundation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Innovations by Katsuhiko Asanuma
Introduction
Katsuhiko Asanuma is a notable inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of renal diseases. With a total of 2 patents, his work has the potential to improve the diagnosis and management of kidney-related disorders.
Latest Patents
Asanuma's latest patents focus on innovative methods for detecting renal disease. One of his inventions is a diagnostic kit and marker for diagnosing renal disease by measuring human megalin in urine. This method includes measuring various forms of human megalin, such as full-length human megalin and its fragments. Another significant patent involves the use of megalin in urine as a marker for detecting renal disorders. This invention provides a straightforward means for identifying renal disorders, enabling prognostic predictions and evaluations of nephropathy stages, particularly in cases like diabetic nephropathy.
Career Highlights
Throughout his career, Asanuma has worked with esteemed institutions, including Niigata University and Denka Seiken Co., Ltd. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Asanuma has collaborated with notable colleagues, including Akihiko Saito and Yasuhiko Tomino. Their joint efforts have further advanced the research and development of diagnostic methods for renal diseases.
Conclusion
Katsuhiko Asanuma's contributions to the field of renal disease diagnostics highlight his innovative spirit and dedication to improving healthcare. His patents represent significant advancements that could enhance the detection and management of kidney disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile